The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
Mario Fritsch NevesWille Oigman

Abstract

Many cardiovascular diseases present renin-angiotensin-aldosterone system (RAAS) hyperactivity as an important pathophysiological mechanism to be target in the therapeutic approaches. Moreover, arterial stiffness is currently considered as a new independent risk factor for cardiovascular disease in different clinical conditions, including hypertension and chronic kidney disease. In fact, excessive stimulation of angiotensin type 1 (AT1) receptors, as well as mineralocorticoid receptors, results in cellular growth, oxidative stress and vascular inflammation, which may lead to arterial stiffness and accelerate the process of vascular aging. In the last decades, a vasoprotective axis of the RAAS has been discovered, and now it is well established that new components with antioxidant and anti-inflammatory properties play important roles promoting vasodilation, natriuresis and reducing collagen deposition, thus attenuating arterial stiffness and improving endothelial function. In this review, we will focus on these pathophysiological mechanisms and the relevance of RAAS inhibition by different strategies to increase arterial compliance and to decelerate vascular aging.

References

Jun 27, 1994·FEBS Letters·A W HahnT J Resink
Jul 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·R KranzhöferW Kübler
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·J E KokoszkaD C Wallace
Mar 7, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·W WojakowskiM Machalski
Mar 9, 2002·Current Hypertension Reports·Frans H H LeenenBing S Huang
Mar 18, 2003·Journal of Hypertension·Justine Ina Davies, Allan D Struthers
Apr 5, 2003·Stroke; a Journal of Cerebral Circulation·Stéphane LaurentPierre Boutouyrie
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robson A S SantosThomas Walther
Dec 10, 2003·Journal of the American College of Cardiology·Carmel M McEnieryIan B Wilkinson
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
May 17, 2005·Journal of the American College of Cardiology·Benjamin D HorneUNKNOWN Intermountain Heart Collaborative Study Group
Dec 29, 2005·American Journal of Physiology. Renal Physiology·Xiao C LiJia L Zhuo
Mar 4, 2006·Circulation Research·Ursula Danilczyk, Josef M Penninger
Jun 21, 2006·The American Journal of Cardiology·Carlos M Ferrario, William B Strawn
Sep 26, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Luis C MatavelliEdward D Frohlich
May 2, 2007·Hypertension·Edward D Frohlich
Jun 9, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Kathryn A BrownFrank M Faraci
Oct 17, 2007·Hypertension·Olga SchmidlinR Curtis Morris
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Nov 26, 2009·BMJ : British Medical Journal·Pasquale StrazzulloFrancesco P Cappuccio
Jan 29, 2010·The American Journal of Clinical Nutrition·Alwyn S ToddRobert J Walker
Mar 27, 2010·Journal of the American College of Cardiology·Charalambos VlachopoulosChristodoulos Stefanadis
May 4, 2010·Physiology & Behavior·Sean D StockerAlan F Sved
Aug 3, 2010·Cardiovascular Drugs and Therapy·Felipe A Martinez
Apr 20, 2011·Nature Reviews. Nephrology·Niloofar NobakhtRobert W Schrier
May 24, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Zoltan UngvariAnna Csiszar
Nov 23, 2012·Journal of Vascular Research·Marie Briet, Ernesto L Schiffrin
Jan 8, 2013·Clinical and Experimental Hypertension : CHE·Murat KaramanErgun Bozoglu

❮ Previous
Next ❯

Citations

Feb 23, 2018·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Agostino Virdis
Oct 23, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O S LevinA V Arablinsky
May 11, 2018·Journal of Applied Physiology·Venkateswara R GogulamudiLisa A Lesniewski
Oct 3, 2018·PM & R : the Journal of Injury, Function, and Rehabilitation·Zoe K SarafisAndrei V Krassioukov
Feb 13, 2019·International Journal of Molecular Sciences·Shaip Krasniqi, Armond Daci
Feb 16, 2019·British Journal of Pharmacology·Jennifer J DuPontIris Z Jaffe
Feb 16, 2019·Current Pharmaceutical Design·Panteleimon PantelidisDragan Lovic
Apr 13, 2018·Minerva cardioangiologica·Eugenio PicanoQuirino Ciampi
Jan 9, 2020·The Journal of Clinical Hypertension·Michelle Rabello Cunha, Mario Fritsch Neves
May 14, 2020·Expert Opinion on Drug Metabolism & Toxicology·Marta Rusek, Stanisław J Czuczwar
Sep 17, 2020·Clinical Science·Yoshito Yamashiro, Hiromi Yanagisawa
Nov 11, 2019·British Journal of Pharmacology·Helbert Gabriel FidelisLeonardo Dos Santos
May 27, 2020·Oxidative Medicine and Cellular Longevity·Arthur José Pontes Oliveira de AlmeidaIsac Almeida de Medeiros
Sep 19, 2020·Journal of Physiology and Biochemistry·Haoran HuangHui Huang
Oct 24, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Caitlyn G KatzelnickJill M Wecht
Apr 4, 2021·International Journal of Molecular Sciences·Mojca LunderMišo Šabovič
Aug 25, 2018·Open Medicine·Hernando Vargas-Uricoechea, Manuel Felipe Cáceres-Acosta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Seminars in Nephrology
Dirk Oliver WennmannHermann Pavenstädt
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Ana Cristina Simões E Silva, Joseph T Flynn
Cardiovascular & Hematological Agents in Medicinal Chemistry
Anna M Grandi, Andrea M Maresca
© 2022 Meta ULC. All rights reserved